LS CancerDiag looks back on the year marked by the achievement of major milestones. 2019 started off with obtaining the CE mark for DiagMMR® as in vitro diagnostic medical device (IVD MD), enabling commercialization in
The last year of this decade has been a very successful one for LS CancerDiag, where many important milestones were achieved, and the basis was laid for strong growth over the coming years. To gear
We are excited to announce that Minttu Kansikas has been appointed as Chief Scientific Officer to lead the research efforts and laboratory functions. Congratulations! Minttu is a co-inventor and one of the leading scientists behind
Welcome! We have updated our website and hope you enjoy the new structure and features! This new section being one of them, and the twitter feed, being another. And there are many more to come!
Day 2 @startuphealth festival! Tune in to the StartUp Health TV live stream, where our CBO Philippe Arnez will be talking about the company mission and our moonshot at 12PM Pacific time (2100 CET) #EndCancer #CancerPrevention #DiagMMR #LynchSyndrome https://www.startuphealth.com/startup-health-tv
